HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Where next for hepatitis B and C surveillance?

Abstract
Hepatitis B and C infections are responsible for significant burden of disease accounting for 1.3 million deaths globally. There is a lack of quality data on the burden of disease due to these infections. One approach to informing policy makers on trends in hepatitis B and C is through case reporting of diagnosed cases. Data on these cases can identify outbreaks of hepatitis and monitor trends in acute and chronic infection. The European Centers for Disease Control (ECDC) has developed standardized case definitions and a harmonized reporting framework. Two articles in this issue summarize the trends in hepatitis B and C infection in Europe. The results show considerable variability in reported cases across countries, reflecting in part differences in testing practices. Risk factor information highlights the continued importance of injecting drug use as a risk factor for hepatitis C infection. Hepatitis case reporting provides valuable information, and more complete reporting will improve the utility of the data. For a comprehensive epidemiologic assessment of the burden of hepatitis, case reporting should be complemented by other sources of data, such as serologic and behavioural surveys.
AuthorsS Z Wiktor
JournalJournal of viral hepatitis (J Viral Hepat) Vol. 22 Issue 7 Pg. 571-3 (Jul 2015) ISSN: 1365-2893 [Electronic] England
PMID25754464 (Publication Type: Journal Article, Review)
Copyright© 2015 John Wiley & Sons Ltd. The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Topics
  • Disease Notification (methods, standards)
  • Epidemiological Monitoring
  • Europe (epidemiology)
  • Hepatitis B (epidemiology, prevention & control)
  • Hepatitis C (epidemiology, prevention & control)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: